Skip to main content
Caplight Logo









BIOVOX GmbH

BIOVOX GmbH

Private
DarmstadtHealthcare & Life Scienceshttps://biovox.systems

Last Round

Seed

Sep 25, 2024

Total Funding Raised

$3M

Company Overview

BIOVOX GmbH is a German manufacturing and CleanTech company that develops, produces, and supplies sustainable, bio-based plastics for the medical technology, pharmaceutical, and laboratory sectors.

Sector

Healthcare & Life Sciences

Verticals

Sustainable Materials, Medical Devices, Advanced Materials, Circular Economy

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical-grade bioplasticsbioplastic granulessustainable medical materialshealthcare bioplasticsbiopolymersbio-based materialspharmaceutical packagingmedical device materialsbiocompatible materialsmedical polymerslow-carbon materialsISO 13485ISO 10993injection molding materialsextrusion materialssterile barrier packagingrecyclable plasticsmaterial consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BIOVOX GmbH Comparables

Compare BIOVOX GmbH with similar companies based on industry and business-model similarity.

BIOVOX GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Innovative Polymer Compounds
72%
Evonik Industries AG
71%
Shenzhen Lando Biomaterials Co., Ltd.
71%

BIOVOX GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 25, 2024
Pre SeedApr 20, 2022

BIOVOX GmbH Investors

Notable investors and investment history

BIOVOX GmbH investors
InvestorRounds
BMH Beteiligungs-Managementgesellschaft HessenSeed
better venturesSeed, Pre Seed
Business Angels FrankfurtRheinMain e.V.Pre Seed, Seed
AuxxoPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 25, 2024

    $2.46M raised from multiple venture capital firms.

  • Apr 20, 2022

    $540K round led by better ventures

BIOVOX GmbH Filings

Explore SEC and related filing metadata, where available.

BIOVOX GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BIOVOX GmbH's valuation, stock price, and market status.

Is BIOVOX GmbH a public or private company?

BIOVOX GmbH is a private company.

What is the current stock price of BIOVOX GmbH?

BIOVOX GmbH is a private company, so its shares have no public market price. Caplight tracks BIOVOX GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BIOVOX GmbH worth (valuation)?

Valuation information for BIOVOX GmbH is not publicly available.

Can I buy BIOVOX GmbH stock?

BIOVOX GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BIOVOX GmbH's last funding round?

BIOVOX GmbH's most recent funding round was Seed on September 25, 2024.

Who are the main investors in BIOVOX GmbH?

Key investors in BIOVOX GmbH include better ventures.

Will BIOVOX GmbH IPO soon?

No public IPO plans have been announced for BIOVOX GmbH.

How can I track BIOVOX GmbH secondary market activity?

Caplight tracks bids, offers, and trades in BIOVOX GmbH's shares on secondary markets.

Firmographic Details

HeadquartersDarmstadt
Employee Range19
Year Founded2021
Last FundingSep 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?